|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income before noncontrolling interests and temporary equity holders | |||||
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: | |||||
| Gains attributable to the fair value of future servicing rights, net of guaranty obligation | |||||
| Change in the fair value of premiums and origination fees (NOTE 2) | |||||
| Amortization and depreciation | |||||
| Stock compensation-equity and liability classified | |||||
| Provision (benefit) for credit losses | |||||
| Indemnified and repurchased loans expenses - loan repurchase losses (Note 5) | |||||
| Deferred tax expense (benefit) | |||||
| Goodwill impairment | |||||
| Fair value adjustments to contingent consideration liabilities | |||||
| Cash paid to settle risk-sharing obligations | |||||
| Impairment of real estate held for investment and equity method investment | |||||
| Originations of loans held for sale | |||||
| Proceeds from transfers of loans held for sale | |||||
| Other operating activities, net | |||||
| Changes in: | |||||
| Receivables, net | |||||
| Other assets | |||||
| Other liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities | |||||
| Capital expenditures | |||||
| Capital invested in equity-method investments | |||||
| Purchases of pledged available-for-sale ("AFS") securities | |||||
| Proceeds from prepayment and sale of pledged AFS securities | |||||
| Distributions from joint ventures | |||||
| Originations and repurchase of loans held for investment | |||||
| Principal collected on loans held for investment | |||||
| Other investing activities, net | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities | |||||
| Borrowings (repayments) of warehouse notes payable, net | |||||
| Repayments of interim warehouse notes payable | |||||
| Repayments of corporate notes payable | |||||
| Borrowings of corporate notes payable | |||||
| Proceeds from issuance of common stock | |||||
| Repurchase of common stock | |||||
| Cash dividends paid | |||||
| Payment of contingent consideration | |||||
| Purchase of noncontrolling interests | |||||
| Debt issuance costs | |||||
| Other financing activities, net | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash, cash equivalents, restricted cash, and restricted cash equivalents (NOTE 2) | |||||
| Cash, cash equivalents, restricted cash, and restricted cash equivalents at beginning of period | |||||
| Total of cash, cash equivalents, restricted cash, and restricted cash equivalents at end of period | |||||
| Supplemental Disclosure of Cash Flow Information: | |||||
| Cash paid to third parties for interest | |||||
| Cash paid for income taxes, net of cash refunds received | |||||
Loading...